Generelt bevaredes følsomheden over for atazanavir (83% af isolaterne viste ændring i EC50på < 2, 5) i isolater, der var resistente over for maksimalt 2 proteasehæmmere.
In general, susceptibility to atazanavir was retained (83% of isolates displayed < 2.5 fold change in EC50) among isolates resistant to no more than 2 protease inhibitors.